Overview
Chronicled uses blockchain to improve supply chain transparency, security, and efficiency for physical goods, especially in the pharmaceutical sector. It builds and runs blockchain networks that record every transaction and movement on a tamper-proof ledger to verify product authenticity and provenance from manufacturer to end user. It collaborates with clients to integrate these solutions into existing systems, offering software development, system integration, and ongoing support, with revenue from service fees, subscriptions, and network usage fees. Its goal is to provide end-to-end, regulated-industry tailored supply chain solutions that enable auditable tracking across multi-party networks, reducing counterfeit risk and building trust among manufacturers, distributors, and regulators.
Work here?Claim your company
Simplify's take
What believers are saying
- Chronicled’s 2026 website sells real-time contract pricing and customer eligibility alignment.
- DSCSA enforcement since November 27, 2024 keeps compliance workflows mandatory.
- NABP bought PVS in June 2023, validating Chronicled’s verification workflow.
What critics are saying
- NABP acquired PVS in June 2023, stripping Chronicled of a core product layer.
- If trading partners standardize on NABP Pulse, Chronicled loses network control.
- MediLedger’s narrow DSCSA scope limits expansion after November 2026 small-dispenser deadline.
What makes Chronicled unique
- MediLedger processes 1.6 billion DSCSA transactions yearly across 27 manufacturers.
- Chronicled solved pharma verification privacy with permissioned blockchain and zero-knowledge proofs.
- The 2023 hospital expansion extended MediLedger beyond distributors into health systems.
Help us improve and share your feedback! Did you find this helpful?